The Advanced Oncotherapy share price is frozen after shares were suspended pending the group’s financial position. But is a comeback in order?
Expand your knowledge with our latest informative articles and helpful resources on companies in the healthcare industry. Start making more informed decisions today.
E-therapeutics successfully completed its fundraiser in 2022. Will the E-therapeutics share price be successful in near future? Let’s explore
ImmuPharma has a very progressive and optimistic path to success. What is the future of ImmuPharma share price? Let’s explore.
The Braveheart share price surged with the news of cancer-identifying test instrument ready for sale. Can it continue to soar? Let’s explore.
AstraZeneca shares have surged by triple digits in the last five years, but is the pharmaceutical stock only just getting started?
The Avacta share price has halved in a year despite reporting encouraging progress. Is this a buying opportunity?
The explosive performance of Ocugen stock created quite the buzz in 2021, but will this happen again in 2022? Saima Naveed investigates.
The demerger of GSK’s consumer healthcare division has transformed the business. Is now the time to invest?
Avacta shares have dropped by nearly 80% in a year. But is now a good time to start buying shares of this promising biotech stock?
Shares of Pfizer have exploded this year but recently the stock has seen some selling pressure. Is this a buying opportunity?
The Moderna share price has exploded in 2021. Saima Naveed explores what’s behind this growth and a potential looming threat.
After years of poor performance, the GSK share price is finally back on the rise. What’s going on? And is now the time to invest?